Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Antiepileptic Drugs: GABAergic Pathway Potentiators01:18

Antiepileptic Drugs: GABAergic Pathway Potentiators

1.1K
γ-aminobutyric acid or GABA, plays a pivotal role as an inhibitory neurotransmitter in the brain. GABA pathway potentiators, also known as GABAergic drugs, are a class of pharmaceutical agents designed to enhance the functioning of the GABAergic system. These medications primarily treat epilepsy, a neurological disorder characterized by recurrent seizures.
The key GABA pathway potentiators used in epilepsy management are as follows.
Benzodiazepines are a well-known class of drugs used for...
1.1K
Antiepileptic Drugs: Glutamate Antagonists01:14

Antiepileptic Drugs: Glutamate Antagonists

782
Glutamate is a fundamental neurotransmitter in the central nervous system, playing a vital role in neuronal communication and various cognitive processes. Glutamate stands as the principal excitatory neurotransmitter in the brain. Its presence is crucial for the communication between neurons, underpinning essential processes such as synaptic transmission, neuronal excitability, and plasticity. These functions are vital for higher-order cognitive processes, including learning and memory. The...
782
Epilepsy and Seizures: Overview01:24

Epilepsy and Seizures: Overview

1.0K
Epilepsy is a chronic neurological disease marked by recurrent, unpredictable seizures. These seizures are caused by abnormal electrical discharges in the brain, leading to behavior, sensation, or consciousness alterations. They can also cause transient impairment of awareness, interfering with daily activities.
Various factors can trigger epilepsy, including genetic factors, brain damage, metabolic causes, and unknown etiology. Diagnosis of epilepsy involves electroencephalography (EEG), which...
1.0K
Antiepileptic Drugs: Modulators of Neurotransmitter Release Mediated by SV2A Protein01:20

Antiepileptic Drugs: Modulators of Neurotransmitter Release Mediated by SV2A Protein

712
Antiepileptic drugs, such as levetiracetam (Keppra) and brivaracetam (Briviact), have emerged as crucial tools in managing epilepsy. These medications exert their therapeutic effects by targeting the synaptic vesicle protein SV2A, a transmembrane glycoprotein primarily found in the brain.
SV2A is a transmembrane glycoprotein located predominantly in the brain, modulating the release of neurotransmitters for neuronal communication. Both levetiracetam and brivaracetam exhibit a high affinity for...
712
Glial Cells01:04

Glial Cells

92.6K
Overview
92.6K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Exploring the Role of the Laforin/Malin Complex in Rubicon-Dependent Phagocytosis.

International journal of molecular sciences·2026
Same author

Glycophagy: A selective autophagy pathway for glycogen degradation.

International review of cell and molecular biology·2026
Same author

Adeno-Associated Virus-Based Gene Therapy for Lafora Disease in <i>Epm2b</i>-Deficient Mice.

International journal of molecular sciences·2025
Same author

An astrocytic cellular model of Lafora disease to study polyglucosan accumulation and inflammation.

Disease models & mechanisms·2025
Same author

Identification of Plasma Growth Factors and Cytokines as Diagnostic Biomarkers for the Lafora Form of Progressive Myoclonus Epilepsy.

International journal of molecular sciences·2025
Same author

Glial Alterations in the Glutamatergic and GABAergic Signalling Pathways in a Mouse Model of Lafora Disease, a Severe Form of Progressive Myoclonus Epilepsy.

Neuropathology and applied neurobiology·2025

Related Experiment Video

Updated: Dec 18, 2025

Triggering Reactive Gliosis In Vivo by a Forebrain Stab Injury
07:46

Triggering Reactive Gliosis In Vivo by a Forebrain Stab Injury

Published on: June 29, 2015

10.9K

Reactive Glia Inflammatory Signaling Pathways and Epilepsy.

Pascual Sanz1, Maria Adelaida Garcia-Gimeno2

  • 1Instituto de Biomedicina de Valencia (CSIC) and Centro de Investigación Biomédica en Red de Enfermedades Raras (CIBERER), Jaime Roig 11, 46010 Valencia, Spain.

International Journal of Molecular Sciences
|June 12, 2020
PubMed
Summary

Neuroinflammation exacerbates epilepsy by promoting seizures, while seizures worsen brain inflammation. This study reviews glial pathways in epilepsy and explores therapeutic targets to break this cycle.

Keywords:
epilepsyinflammationmicrogliareactive astrocytessignaling pathways

More Related Videos

Lipidomics and Transcriptomics in Neurological Diseases
09:58

Lipidomics and Transcriptomics in Neurological Diseases

Published on: March 18, 2022

3.8K
Improved 3D Hydrogel Cultures of Primary Glial Cells for In Vitro Modelling of Neuroinflammation
09:19

Improved 3D Hydrogel Cultures of Primary Glial Cells for In Vitro Modelling of Neuroinflammation

Published on: December 8, 2017

15.4K

Related Experiment Videos

Last Updated: Dec 18, 2025

Triggering Reactive Gliosis In Vivo by a Forebrain Stab Injury
07:46

Triggering Reactive Gliosis In Vivo by a Forebrain Stab Injury

Published on: June 29, 2015

10.9K
Lipidomics and Transcriptomics in Neurological Diseases
09:58

Lipidomics and Transcriptomics in Neurological Diseases

Published on: March 18, 2022

3.8K
Improved 3D Hydrogel Cultures of Primary Glial Cells for In Vitro Modelling of Neuroinflammation
09:19

Improved 3D Hydrogel Cultures of Primary Glial Cells for In Vitro Modelling of Neuroinflammation

Published on: December 8, 2017

15.4K

Area of Science:

  • Neuroscience
  • Immunology
  • Epileptology

Background:

  • Neuroinflammation and epilepsy share a bidirectional relationship.
  • Glial immune-inflammatory dysregulation contributes to seizure generation.
  • Seizures activate glial cells, increasing pro-inflammatory cytokines.

Purpose of the Study:

  • To review glial signaling pathways in neuroinflammation and epilepsy.
  • To examine how these pathways are altered in epileptic conditions.
  • To identify therapeutic opportunities targeting glial pathways.

Main Methods:

  • Literature review of glial signaling in neuroinflammation.
  • Analysis of glial pathway involvement in epilepsy.
  • Exploration of therapeutic strategies.

Main Results:

  • Glial cells (microglia and astrocytes) play a central role in the neuroinflammatory response.
  • Dysfunctional glial signaling contributes to neuronal hyperexcitability and seizures.
  • A positive feedback loop exists between seizures and inflammatory mediators.

Conclusions:

  • Targeting glial signaling pathways offers potential therapeutic avenues for epilepsy.
  • Understanding the interplay between neuroinflammation and epilepsy is crucial for developing effective treatments.
  • Modulating glial function may help prevent or treat seizure disorders.